ClinicalTrials.Veeva

Menu

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes (REFLECT2DPilot)

University of Pittsburgh logo

University of Pittsburgh

Status

Not yet enrolling

Conditions

Lifestyle (Sedentary Behavior and Physical Activity)
Physical Inactivity
Hyperglycemia
Continuous Glucose Monitoring
Diabetes Mellitus, Type 2

Treatments

Other: Healthmine app

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07270016
STUDY25100193
1R01DK137803-01A1 (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Enrollment

30 estimated patients

Sex

All

Ages

16 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages 16-24 years, any sex or gender
  • Diagnosis of type 2 diabetes in childhood (younger than 18 years of age)
  • English-speaking (app in English)
  • Possession of personal smartphone that is compatible with FreeStyle Libre app

Exclusion criteria

• Cognitive impairment or severe psychiatric conditions that could interfere with participation in behavioral intervention for diabetes self-management

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Single-arm pilot study
Experimental group
Description:
Participants will engage in pilot-testing a novel smartphone app supporting health behavior change and wear a continuous glucose monitoring device and Fitbit physical activity tracker for 30 days. Questionnaires and interviews will be used to gather participant experiences with the app and device wear.
Treatment:
Other: Healthmine app

Trial contacts and locations

1

Loading...

Central trial contact

Mary Ellen Vajravelu, MD, MSHP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems